View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

Capricor Hope-3 study

Phase: III
Clinicaltrials.gov ID: NCT05126758

What is the goal of the study?

The purpose of the clinical trial is to assess the efficacy and safety of the investigational product (IP), CAP-1002, administered every 3 months by IV infusion in subjects with Duchenne muscular dystrophy and impaired skeletal muscle function.

Who can participate in the study?

Everyone

Study Team:

PI (Study Doctor): Seth Perlman
Study Team Member: Margot Amalachandran, margot.amalachandran@seattlechildrens.org